4.6 Article

Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study

Malgorzata Mikulska et al.

Summary: The study found that levels of (1,3)-beta-d-glucan (BDG) released by Candida auris strains were lower compared to Candida albicans strains. The sensitivity of serum BDG for diagnosing C. auris candidemia was found to be lower, which may have implications for management protocols in high-prevalence areas.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Editorial Material Critical Care Medicine

Is (1,3)-β-D-glucan useless to guide antifungal therapy in ICU?

Anahita Rouze et al.

INTENSIVE CARE MEDICINE (2022)

Article Critical Care Medicine

(1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial

Frank Bloos et al.

Summary: Serum BDG-guided antifungal treatment did not decrease the 28-day mortality of sepsis patients at high risk for invasive Candida infection, but it did shorten the duration of antifungal therapy.

INTENSIVE CARE MEDICINE (2022)

Review Dermatology

Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis

Daniele Roberto Giacobbe et al.

Summary: This systematic review summarizes the diagnostic performance of clinical scores and laboratory tests for invasive candidiasis (IC) in critically ill, nonneutropenic adult patients in the Intensive Care Unit (ICU). Clinical scores consistently showed a high negative predictive value (NPV) and a low positive predictive value (PPV), while fungal antigen-based biomarkers retained a high NPV similar to clinical scores with a higher PPV but with heterogeneity across studies.

MYCOSES (2022)

Article Microbiology

Beta-D-Glucan in Patients with Haematological Malignancies

Malgorzata Mikulska et al.

Summary: This article summarizes the data on the use of BDG in screening and diagnostic testing in patients with haematological malignancies, highlighting the advantages and limitations of BDG in diagnosis, and emphasizing the recommendation to combine it with other diagnostic methods for maximum information.

JOURNAL OF FUNGI (2021)

Article Infectious Diseases

Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study

Joveria Farooqi et al.

Summary: This study compared serum BDG levels in patients with different Candida species, finding that BDG levels were lower in C. auris and the sensitivity of serum BDG was also lower for C. auris compared to other species. Therefore, more sensitive testing methods are needed to improve the detection accuracy of C. auris infection.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Microbiology

Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis

Antonios Kritikos et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Article Critical Care Medicine

ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients

Ignacio Martin-Loeches et al.

INTENSIVE CARE MEDICINE (2019)

Review Microbiology

New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies

Thomas F. Patterson et al.

JOURNAL OF FUNGI (2019)

Article Infectious Diseases

Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis

M. Mikulska et al.

CLINICAL MICROBIOLOGY AND INFECTION (2016)

Article Critical Care Medicine

β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis

Estrella Martin-Mazuelos et al.

INTENSIVE CARE MEDICINE (2015)

Article Infectious Diseases

Candida biomarkers in patients with candidaemia and bacteraemia

M. Carmen Martinez-Jimenez et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)

Review Infectious Diseases

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

O. A. Cornely et al.

CLINICAL MICROBIOLOGY AND INFECTION (2012)

Review Immunology

β-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

Drosos E. Karageorgopoulos et al.

CLINICAL INFECTIOUS DISEASES (2011)